The Immutep Ltd (ASX: IMM) share price has been a strong performer again on Thursday.
In morning trade, the biotechnology company’s shares are storming 10% higher to 48.5 cents.
Why is the Immutep share price storming higher?
Investors have been buying Immutep’s shares following the release of its second announcement in as many days.
On this occasion, the company has provided an update on its lead product candidate, eftilagimod alpha.
According to the release, the soluble LAG-3 protein, which is better known as efti or IMP321, has received Fast Track designation in first line recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) from the United States Food and Drug Administration (FDA).
The company notes that it…